Labomar SpA
MIL:LBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (2), the stock would be worth €9.95 (0% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2 | €9.95 |
0%
|
| 3-Year Average | 2 | €9.95 |
0%
|
| 5-Year Average | 2 | €9.95 |
0%
|
| Industry Average | 0.7 | €3.64 |
-63%
|
| Country Average | 1.2 | €6.17 |
-38%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
€183.9m
|
/ |
Jan 2023
€91.8m
|
= |
|
|
€183.9m
|
/ |
Dec 2023
€96.9m
|
= |
|
|
€183.9m
|
/ |
Dec 2024
€105.1m
|
= |
|
|
€183.9m
|
/ |
Dec 2025
€121.2m
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
L
|
Labomar SpA
MIL:LBM
|
183.9m EUR | 2 | 29.9 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.2B EUR | 4.4 | 31.6 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
91.9B GBP | 2.1 | 11.4 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR | 8.1 | 36.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.3B GBP | 2.8 | 18.3 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.4B USD | 1.9 | -153.8 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.4B EUR | 1.5 | 16.2 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 1.6 | 22 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 7.3 | 61.1 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 855.7 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
808.8B INR | 6 | 42.5 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 0.7 |
| Median | 1.2 |
| 70th Percentile | 2.1 |
| Max | 55 240 |
Other Multiples
Labomar SpA
Glance View
Labomar SpA operates as a contract development manufacturing organization which specializes in the research, development, and production of food supplements, medical equipment, food for special medical purposes, and cosmetics on behalf of third parties. The company is headquartered in Treviso, Treviso and currently employs 342 full-time employees. The company went IPO on 2020-10-05. is an Italy-based company, which produces dietary supplements, in either solid format or as liquids. The firm's oral solid products include chewable tablets, swallable tablets, coated tablets, gastro-resistant tablets, time release tablets, micro tablets, hard plant or animal gelatine capsules, oro dispersible powders, and water dispersible powders. Its oral liquid products include syrups, hydroglyceric and hydroalcoholic suspensions, solutions, emulsions, and nanoemulsions. The firm serves companies operating in the medical information sector, in distribution channels in chemist and herbalists shops, retail stores of products for athletes and retail organization.
